Psychological distress of patients suffering from restless legs syndrome: A cross-sectional study

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Scholz, Hanna ^a   Benes, Heike ^b,c   Happe, Svenja ^d,e   Bengel, Juergen ^f   Kohnen, Ralf ^g,h   Hornyak, Magdolna ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Somni Bene Institute for Medical Research and Sleep Medicine   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d KLINIKUM BREMEN OST   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g Research Pharmaceutical Services Inc   (United States)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Anxiety; Compulsivity; Depression; Psychological impairment; Psychopathology; Restless legs syndrome; Somatisation

Indexed keywords

ANTICONVULSIVE AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; OPIATE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISTRESS SYNDROME; FEMALE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARANOIA; PHOBIA; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; SYMPTOM CHECKLIST 90; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; GERMANY; HOSPITALIZATION; MENTAL STRESS; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL;

EID: 80053173766     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-73     Document Type: Article

References (38)

1. Berger K, Kurth T. RLS epidemiology--frequencies, risk factors and methods in population studies. Mov Disord 2007, 22(Suppl 18):S420-423.
2. Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165:1286-1292. 10.1001/archinte.165.11.1286, 15956009.
3. Happe S, Reese JP, Stiasny-Kolster K, Peglau I, Mayer G, Klotsche J, Giani G, Geraedts M, Trenkwalder C, Dodel R. Assessing health-related quality of life in patients with restless legs syndrome. Sleep Med 2009, 10:295-305. 10.1016/j.sleep.2008.01.002, 18359664.
4. Winkelmann J, Prager M, Lieb R, Pfister H, Spiegel B, Wittchen HU, Holsboer F, Trenkwalder C, Strohle A. "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome. J Neurol 2005, 252:67-71. 10.1007/s00415-005-0604-7, 15654556.
5. Lee HB, Hening WA, Allen RP, Kalaydjian AE, Earley CJ, Eaton WW, Lyketsos CG. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 2008, 20:101-105. 10.1176/appi.neuropsych.20.1.101, 18305292.
6. Cho SJ, Hong JP, Hahm BJ, Jeon HJ, Chang SM, Cho MJ, Lee HB. Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep 2009, 32:1069-1076. 2717197, 19725258.
7. Kushida CA, Allen RP, Atkinson MJ. Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS. Sleep Med 2004, 5:485-488. 10.1016/j.sleep.2004.04.004, 15341894.
8. Winkelman JW, Redline S, Baldwin CM, Resnick HE, Newman AB, Gottlieb DJ. Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. Sleep 2009, 32:772-778. 2690565, 19544754.
9. Scholz H, Trenkwalder C, Kohnen R, Kriston L, Riemann D, Hornyak M. Dopamine agonists for restless legs syndrome. Cochrane Database of Systematic Reviews 2011, (3). Art. No.: CD006009.
10. Kume A, Kume H. [Clinical features of idiopathic restless legs syndrome in Japanese patients]. Rinsho Shinkeigaku 2010, 50:385-392. 10.5692/clinicalneurol.50.385, 20593663.
11. Trenkwalder C, Benes H, Poewe W, Oertel WH, Garcia-Borreguero D, de Weerd AW, Ferini-Strambi L, Montagna P, Odin P, Stiasny-Kolster K, et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2008, 7:595-604. 10.1016/S1474-4422(08)70112-1, 18515185.
12. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003, 163:2433-2445. 10.1001/archinte.163.20.2433, 14609780.
13. Kalaydjian A, Bienvenu OJ, Hening WA, Allen RP, Eaton WW, Lee HB. Restless Legs Syndrome and the five-factor model of personality: results from a community sample. Sleep Med 2009, 10:672-675. 10.1016/j.sleep.2008.07.004, 18996740.
14. Derogatis L. SCL-90-R. Self-Report Symptom Inventory. Collegium Internationale Psychiatriae Scalarum, Internationale Skalen für Psychiatrie 1986, Weinheim: Beltz.
15. Franke G. Die Symptom-Checkliste von Derogatis - deutsche Version 2002, Göttingen: Beltz Test GmbH.
16. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101-119. 10.1016/S1389-9457(03)00010-8, 14592341.
17. Benes H, Kohnen R. Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI). Sleep Med 2009, 10:515-523. 10.1016/j.sleep.2008.06.006, 18823819.
18. Hardt J, Gerbershagen HU, Franke P. The symptom check-list, SCL-90-R: its use and characteristics in chronic pain patients. Eur J Pain 2000, 4:137-148. 10.1053/eujp.2000.0162, 10957695.
19. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II 1996, San Antonio, TX: Psychological Corporation.
20. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996, 67(3):588-97. 10.1207/s15327752jpa6703_13, 8991972.
21. Harris CA, D'Eon JL. Psychometric properties of the Beck Depression Inventory--second edition (BDI-II) in individuals with chronic pain. Pain 2008, 137(3):609-22. 10.1016/j.pain.2007.10.022, 18079063.
22. Kühner C, Bürger C, Keller F, Hautzinger M. [Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results from German samples]. Nervenarzt 2007, 78(6):651-6. 10.1007/s00115-006-2098-7, 16832698.
23. Segal DL, Coolidge FL, Cahill BS, O'Riley AA. Psychometric properties of the Beck Depression Inventory II (BDI-II) among community-dwelling older adults. Behav Modif 2008, 32(1):3-20. 10.1177/0145445507303833, 18096969.
24. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121-132.
25. Hessel A, Schumacher J, Geyer M, Brähler E. [Symptom-Checklist SCL-90-R: Validation and standardization based on a representative sample of the German population]. Diagnostica 2001, 47:27-39.
26. Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 2006, 26:451-456. 10.1111/j.1468-2982.2005.01060.x, 16556247.
27. Offenbaecher M, Glatzeder K, Ackenheil M. Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Rheumatol 1998, 57(Suppl 2):94-96.
28. Parker JC, Buckelew SP, Smarr KL, Buescher KL, Beck NC, Frank RG, Anderson SK, Walker SE. Psychological screening in rheumatoid arthritis. J Rheumatol 1990, 17:1016-1021.
29. Sala I, Roig C, Amador-Campos JA, Garcia-Sanchez C, Rodriguez A, Diaz C, Gich I. [Psychopathological symptoms in patients suffering from chronic cephalea with or without fibromyalgia]. Rev Neurol 2009, 49:281-287.
30. Glazer Y, Cohen H, Buskila D, Ebstein RP, Glotser L, Neumann L. Are psychological distress symptoms different in fibromyalgia patients compared to relatives with and without fibromyalgia?. Clin Exp Rheumatol 2009, 27:S11-15.
31. Godau J, Spinnler N, Wevers AK, Trenkwalder C, Berg D. Poor effect of guideline based treatment of restless legs syndrome in clinical practice. J Neurol Neurosurg Psychiatry 2010, 81:1390-1395. 10.1136/jnnp.2010.211417, 20884674.
32. Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord 2009, 24:1561-1570. 10.1002/mds.22505, 19526584.
33. Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010, 33:81-87. 2802252, 20120624.
34. Salas R, Allen RP, Earley CJ, Gamaldo CE. Drug hoarding: a case of atypical dopamine dysregulation syndrome in a RLS patient. Movement Disorders 2009, 24:627-628. 10.1002/mds.22443, 19133660.
35. Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs 2010, 24:89-98. 10.2165/11317500-000000000-00000, 20088617.
36. Hornyak M, Scholz H, Kohnen R, Grossmann C, Riemann D, Berger M. Bewältigungsstrategien beim Restless-legs-Syndrom [Coping strategies in restless legs syndrome]. Somnologie 2010, 14:61-66.
37. Hornyak M, Grossmann C, Kohnen R, Schlatterer M, Richter H, Voderholzer U, Riemann D, Berger M. Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial. J Neurol Neurosurg Psychiatry 2008, 79:823-825. 10.1136/jnnp.2007.138867, 18303103.
38. Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep 2009, 32:589-597. 2675893, 19480225.